|
KemstroDrug - Kemstro The trade name of the product as shown on the labeling.
Dosage -
TABLET, ORALLY DISINTEGRATING; ORAL
Active Ingredient(s) -
Baclofen
Strength -
10MG
Applicant -
SCHWARZ PHARMA
New Drug Application (NDA) Number -
021589
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 30, 2003
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Schwarz Pharma Inc
Kemstro
Bacitracin-neomycin-polymyxin W/ Hydrocortisone Acetate 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Mycitracin 500 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Lanabiotic 500 Units/gm;5,000 Units/gm Disc; Topical Lioresal 0.05mg/ml Injectable; Intrathecal Lioresal 0.5mg/ml Injectable; Intrathecal Lioresal 2mg/ml Injectable; Intrathecal Kemstro 10mg Tablet, Orally Disintegrating; Oral Polysporin 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic Bacitracin Zinc-polymyxin B Sulfate 500 Units/gm;10,000 Units/gm Ointment; Topical Bacitracin-neomycin-polymyxin W/ Hydrocortisone Acetate 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic NewDrugInformation |